CSI Market
Sign In | Register

Dr Reddy s Laboratories Limited (RDY) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access RDY Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Dr Reddy s Laboratories Limited adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
12 Months 		0 0 0 (Mar 31 2025)
Operating Activities
Income452.00
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss38.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Adjustments For Losses Gains On Disposal Of Noncurrent Assets-27.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-31.00
Adjustments For Decrease Increase In Trade And Other Receivables-
Adjustments For Decrease Increase In Inventories-
Adjustments For Increase Decrease In Trade And Other Payables-
Adjustments For Income Tax Expense-
Adjustments For Fair Value Increase Decrease And Gains Losses On Disposals Mutual Funds-
Adjustments For Depreciation And Amortisation Expense-
Additional Allowance Recognised In Profit Or Loss Allowance Account For Credit Losses Of Financial Assets-
Gains Losses On De Recognition Of Noncurrent Assets-
Share Of Profit Loss Of Associates Accounted For Using Equity Method-
Adjustments For Sharebased Payments-
Income Taxes Paid Classified As Operating Activities-
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities-161.00
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Interest Revenue Expense0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1,011.00
Discontinued operations0.00
Net Cash flow from Operating Activities1,358.00
Investing Activities
Capital Expenditures-249.00
Sale of Capital Items3.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Purchase Of Investments Other Than Investments Accounted For Using Equity Method-498.00
Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method-
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities-
Interest And Dividend Received-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-147.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-700.00
Financing Activities
Short-term debt Net215.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-43.00
Proceeds From Repayments Of Noncurrent Borrowings-
Payments To Acquire Or Redeem Entitys Shares-
Proceeds From Current Borrowings-
Payments Of Lease Liabilities-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-71.00
Net Cash Flow from Financing Activities88.00
Effect of exchange rate on cash flow-5.00
Discontinued operations0.00
Free Cash Flow1,112.00
Total Cash Flow741.00
4 historic quarters locked

Sign in to unlock the full Dr Reddy s Laboratories Limited cash flow history.

Sign In Create Free Account

About Dr Reddys Laboratories Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

  • Form: 20-F (Period: 20260331)
  • Filed with the SEC: May 29, 2026
  • Source: rdy0899_20f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001575872-26-000381

Figures are derived from filed reports and may be restated. Historical data is subject to revision.